CCNE1 and hepatocellular carcinoma: Furthermore, exosome RNPs showed solid therapeutic potential in acute liver injury, chronic liver fibrosis, and hepatocellular carcinoma mouse models by targeting PUMA, CcnE1, and KAT5, respectively.